Scarica l'app Stockscreener
6.88
0.44%
0.03
Precedente Chiudi:
$6.85
Aprire:
$6.85
Volume 24 ore:
1,275
Relative Volume:
0.18
Capitalizzazione di mercato:
$61.42M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.29%
1M Prestazione:
+0.44%
6M Prestazione:
-6.39%
1 anno Prestazione:
+30.06%
Intervallo 1D:
$6.82
$6.88
Intervallo di 1 settimana:
$6.81
$6.88
Portata 52W:
$3.79
$7.66
Neuehealth Inc Stock (NEUE) Company Profile
Nome
Neuehealth Inc
Settore
Industria
Telefono
612-238-1321
Indirizzo
9250 NW 36TH STREET, DORAL
Confronta NEUE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NEUE
Neuehealth Inc
|
6.88 | 61.42M | 0 | 0 | 0 | 0.00 |
|
UNH
Unitedhealth Group Inc
|
286.46 | 264.62B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
302.12 | 80.79B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
61.34 | 80.89B | 378.96B | 5.28B | 5.94B | 4.19 |
|
ELV
Elevance Health Inc
|
286.18 | 75.71B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
232.40 | 26.78B | 117.76B | 1.21B | 2.39B | 9.95 |
Neuehealth Inc Stock (NEUE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-10-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-03-29 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-03-04 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-03-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2022-01-10 | Ripresa | Citigroup | Neutral |
| 2021-12-16 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2021-12-14 | Iniziato | Goldman | Neutral |
| 2021-12-10 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-11-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-02 | Downgrade | Cowen | Outperform → Market Perform |
| 2021-11-01 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-08-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-08-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-07-19 | Iniziato | Goldman | Buy |
| 2021-07-19 | Iniziato | JP Morgan | Neutral |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-07-19 | Iniziato | Wolfe Research | Peer Perform |
Mostra tutto
Neuehealth Inc Borsa (NEUE) Ultime notizie
What analysts say about NeueHealth Inc. stockHigh-velocity gains - jammulinksnews.com
Is NeueHealth Inc. a good long term investmentHigh-yield capital appreciation - jammulinksnews.com
What drives NeueHealth Inc. stock priceFree Stock Market Forecast Reports - jammulinksnews.com
NeueHealth Inc. Stock Analysis and ForecastBreakthrough financial growth - jammulinksnews.com
NeueHealth Q4 Net Loss Narrows, Stock Up In Pre-market - 富途牛牛
NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025 - Business Wire
Why NeueHealth Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser
What makes NeueHealth Inc. stock price move sharplyFree Access to Group - Newser
How NeueHealth Inc. stock performs during market volatilityLow Risk Trade Timing Signals - Newser
NeueHealth Stock Soars Toward 9-Month Highs On $1.3B Take-Private Deal: Retail Exuberant - MSN
NeueHealth (NYSE:NEUE) and Oncology Institute (NASDAQ:TOI) Head to Head Comparison - Defense World
Northern Trust Corp Increases Stock Position in NeueHealth, Inc. (NYSE:NEUE) - Defense World
NeueHealth Inc Holds Annual Stockholders Meeting - TipRanks
NeueHealth (NYSE:NEUE) Trading Down 2% – What’s Next? - Defense World
How Bright Health went from insurtech darling to cautionary tale - Modern Healthcare
NeueHealth's Q1 2025: Key Contradictions in Consumer Growth, Revenue, and Profitability - AInvest
After spinoff, 3M is no longer one of Minnesota’s five largest public companies - Star Tribune
neueHealth CFO Matushak sells $3,190 in common stock - Investing.com Australia
neueHealth CFO Matushak sells $3,190 in common stock By Investing.com - Investing.com Nigeria
NeueHealth Inc. Reports Strong Start to 2025 - TipRanks
UnitedHealth’s financial miscues, and an $800 million revenue cycle bonanza - statnews.com
NeueHealth, Inc. SEC 10-Q Report - TradingView
NeueHealth Q1 2025 slides: improved margins offset revenue decline - Investing.com
NeueHealth: Q1 Earnings Snapshot - New Haven Register
Neuehealth Inc Azioni (NEUE) Dati Finanziari
Non sono disponibili dati finanziari per Neuehealth Inc (NEUE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.52%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):